Literature DB >> 2649803

The calcium deficiency model for osteoporosis.

B E Nordin, H A Morris.   

Abstract

Calcium deficiency causes osteoporosis in experimental animals because the skeleton is sacrificed for the preservation of the plasma (ionic) calcium and to meet obligatory calcium losses in the feces and urine. (Vitamin D deficiency, on the other hand, causes rickets and osteomalacia largely because of the loss of the calcemic action of vitamin D, which leads to hypocalcemia, secondary hyperparathyroidism, and hypophosphatemia.) The concept that human osteoporosis, particularly in postmenopausal women, results from negative calcium balance represents a working hypothesis that fits many, but not all of the available data. In normal women, the crucial event is a rise in obligatory urinary calcium loss, which may result from an increase in the complexed fraction of the plasma calcium, due in turn to an increase in plasma bicarbonate. Prospective trials with calcium supplements have, however, yielded conflicting results. In osteoporotic women, a further increase in urinary calcium combined with calcium malabsorption produces a further increase in bone resorption, but some impairment of bone formation due to declining androgens may constitute an additional risk factor with advancing age. The suppressibility of urinary hydroxyproline by calcium supplementation in those patients who can absorb calcium, and by calcitriol in those who cannot, supports the calcium deficiency model, but more trials are needed to establish its validity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2649803     DOI: 10.1111/j.1753-4887.1989.tb02794.x

Source DB:  PubMed          Journal:  Nutr Rev        ISSN: 0029-6643            Impact factor:   7.110


  10 in total

Review 1.  Calcium supplementation of the diet: justified by present evidence.

Authors:  B E Nordin; R P Heaney
Journal:  BMJ       Date:  1990-04-21

2.  Effect of ovariectomy on bone histology and plasma parameters of bone metabolism in nulliparous and multiparous sows.

Authors:  K E Scholz-Ahrens; G Delling; P W Jungblut; E Kallweit; C A Barth
Journal:  Z Ernahrungswiss       Date:  1996-03

Review 3.  Who are candidates for prevention and treatment for osteoporosis?

Authors: 
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

4.  Diminished bone resorption in rats after oral xylitol administration: a dose-response study.

Authors:  P Mattila; M Svanberg; M Knuuttila
Journal:  Calcif Tissue Int       Date:  1995-03       Impact factor: 4.333

Review 5.  Calcium requirements for optimal skeletal health in women.

Authors:  J A Kanis
Journal:  Calcif Tissue Int       Date:  1991       Impact factor: 4.333

6.  Increased bone resorption precedes increased bone formation in the ovariectomized rat.

Authors:  N A Sims; H A Morris; R J Moore; T C Durbridge
Journal:  Calcif Tissue Int       Date:  1996-08       Impact factor: 4.333

Review 7.  Calcitriol. A review of its use in the treatment of postmenopausal osteoporosis and its potential in corticosteroid-induced osteoporosis.

Authors:  K L Dechant; K L Goa
Journal:  Drugs Aging       Date:  1994-10       Impact factor: 3.923

Review 8.  The aging spine: new technologies and therapeutics for the osteoporotic spine.

Authors:  Joseph M Lane; Michael J Gardner; Julie T Lin; Marjolein C van der Meulen; Elizabeth Myers
Journal:  Eur Spine J       Date:  2003-10-08       Impact factor: 3.134

9.  Biochemical and physiologic consequences of boron deprivation in humans.

Authors:  F H Nielsen
Journal:  Environ Health Perspect       Date:  1994-11       Impact factor: 9.031

10.  Evaluation of an Ionic Calcium Fiber Supplement and Its Impact on Bone Health Preservation in a Dietary Calcium Deficiency Mice Model.

Authors:  Sara Elisa Herrera-Rodríguez; Eristeo García-Márquez; Eduardo Padilla-Camberos; Hugo Espinosa-Andrews
Journal:  Nutrients       Date:  2022-01-18       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.